{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:10:13Z","timestamp":1759065013164,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104895","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:01:54Z","timestamp":1596308514000},"page":"104895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-3843","authenticated-orcid":false,"given":"Peter G.","family":"Mohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8133-1263","authenticated-orcid":false,"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor A.","family":"Streltsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-6786","authenticated-orcid":false,"given":"Jennifer L.","family":"McKimm-Breschkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104895_bib1","doi-asserted-by":"crossref","first-page":"104561","DOI":"10.1016\/j.antiviral.2019.104561","article-title":"The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors","volume":"170","author":"Abed","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104895_bib2","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104895_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3201\/eid2304.161876","article-title":"Antiviral drug-resistant influenza B viruses carrying H134N substitution in neuraminidase, Laos, February 2016","volume":"23","author":"Baranovich","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104895_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023627","article-title":"Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses","volume":"6","author":"Barrett","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104895_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/viro.1995.0058","article-title":"Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en","volume":"214","author":"Blick","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104895_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid","volume":"11","author":"Burmeister","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104895_bib7","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/AAC.02628-13","article-title":"Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y","volume":"58","author":"Burnham","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib8","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/jvi.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase","volume":"67","author":"Colman","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104895_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104895_bib10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/infdis\/jiu244","article-title":"A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses","volume":"210","author":"Escuret","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104895_bib11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/jac\/dkv065","article-title":"Influenza viruses with B\/Yamagata- and B\/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility","volume":"70","author":"Farrukee","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm3009713","article-title":"Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors","volume":"56","author":"Feng","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104895_bib13","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/infdis\/jis571","article-title":"Presence of oseltamivir-resistant pandemic A\/H1N1 minor variants before drug therapy with subsequent selection and transmission","volume":"206","author":"Ghedin","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104895_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsb.2017.12.014","article-title":"A novel small molecule displays two different binding modes during inhibiting H1N1 influenza A virus neuraminidases","volume":"202","author":"Guan","year":"2018","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.antiviral.2020.104895_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016","volume":"146","author":"Gubareva","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104895_bib16","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/AAC.45.12.3403-3408.2001","article-title":"Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants","volume":"45","author":"Gubareva","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jiac.2018.05.003","article-title":"Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China","volume":"24","author":"Huang","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","article-title":"Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient","volume":"50","author":"Hurt","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1099\/jgv.0.001029","article-title":"An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness","volume":"99","author":"Kwon","year":"2018","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104895_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/irv.12187","article-title":"Peramivir and laninamivir susceptibility of circulating influenza A and B viruses","volume":"8","author":"Leang","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2020.104895_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00151829-200504020-00004","article-title":"Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance","volume":"4","author":"McKimm-Breschkin","year":"2005","journal-title":"Treat. Respir. Med."},{"key":"10.1016\/j.antiviral.2020.104895_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.12.004","article-title":"Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation","volume":"114","author":"McKimm-Breschkin","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104895_bib23","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jac\/dks150","article-title":"In vitro passaging of a pandemic H1N1\/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir","volume":"67","author":"McKimm-Breschkin","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib24","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dkt205","article-title":"Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase","volume":"68","author":"McKimm-Breschkin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2011.04.010","article-title":"Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors","volume":"91","author":"Mohr","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104895_bib26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib27","doi-asserted-by":"crossref","first-page":"e1305","DOI":"10.1371\/journal.pone.0001305","article-title":"A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination","volume":"2","author":"Morrison","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104895_bib28","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm100621s","article-title":"Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses","volume":"53","author":"Oakley","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104895_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128072-200103030-00005","article-title":"Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children","volume":"3","author":"Oo","year":"2001","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.antiviral.2020.104895_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"year":"2010","series-title":"The PyMOL Molecular Graphics System","author":"Schrodinger","key":"10.1016\/j.antiviral.2020.104895_bib31"},{"key":"10.1016\/j.antiviral.2020.104895_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000-2001 and 2001-2002 seasons","volume":"303","author":"Shaw","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104895_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104895_bib34","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1007\/s00216-013-7068-x","article-title":"Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry","volume":"405","author":"Swaminathan","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.antiviral.2020.104895_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104895_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3851\/IMP1194","article-title":"Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007","volume":"14","author":"Tashiro","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104895_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.00588-08","article-title":"Pharmacokinetics of high-dose oseltamivir in healthy volunteers","volume":"53","author":"Wattanagoon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104895_bib38","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"year":"2018","series-title":"Summary of Neuraminidase Amino Acid Substitutions Associated with Reduced Inhibition by Neuraminidase Inhibitors","author":"WHO","key":"10.1016\/j.antiviral.2020.104895_bib39"},{"key":"10.1016\/j.antiviral.2020.104895_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00396-13","article-title":"Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R\/K viral population","volume":"4","author":"Yen","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2020.104895_bib41","doi-asserted-by":"crossref","first-page":"18903","DOI":"10.1073\/pnas.1212579109","article-title":"Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site","volume":"109","author":"Zhu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:29Z","timestamp":1759062749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"alternative-id":["S0166354220303090"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104895","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104895"}}